We serve Chemical Name:5-piperidin-3-yl-3-propyl-1,2,4-oxadiazole CAS:902837-18-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-piperidin-3-yl-3-propyl-1,2,4-oxadiazole
CAS.NO:902837-18-7
Synonyms:3-(3-Propyl-1,2,4-oxadiazol-5-yl)piperidine;5-(Piperidin-3-yl)-3-propyl-1,2,4-oxadiazole
Molecular Formula:C10H17N3O
Molecular Weight:195.26100
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:50.95000
Exact Mass:195.13700
LogP:1.81790
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(3-Propyl-1,2,4-oxadiazol-5-yl)piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(Piperidin-3-yl)-3-propyl-1,2,4-oxadiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(Piperidin-3-yl)-3-propyl-1,2,4-oxadiazole Use and application,3-(3-Propyl-1,2,4-oxadiazol-5-yl)piperidine technical grade,usp/ep/jp grade.
Related News: There are also new directives that relate to US citizens. 5-piperidin-3-yl-3-propyl-1,2,4-oxadiazole manufacturer The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured. 5-piperidin-3-yl-3-propyl-1,2,4-oxadiazole supplier The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 5-piperidin-3-yl-3-propyl-1,2,4-oxadiazole vendor Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 5-piperidin-3-yl-3-propyl-1,2,4-oxadiazole factory There are also new directives that relate to US citizens.
